Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
11.98
+0.70 (6.21%)
Jun 15, 2026, 2:19 PM EDT - Market open
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.8 billion as of June 15, 2026. Its market cap has increased by 19.27% in one year.
Market Cap
1.80B
Enterprise Value
1.65B
1-Year Change
19.27%
Ranking
Category
Stock Price
$11.98
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.80B, an increase of 589.55%. That is a compound annual growth rate of 67.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 1.80B | 20.40% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.75B |
| Agios Pharmaceuticals | 1.75B |
| uniQure | 1.74B |
| Nuvation Bio | 1.71B |
| Intellia Therapeutics | 1.69B |
| MBX Biosciences | 1.69B |
| Innoviva | 1.68B |
| Recursion Pharmaceuticals | 1.67B |